Fas ligand

Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer
M W Bennett, J O’Connell, G C O’Sullivan, D Roche, C Brady, J Kelly, J K Collins, F Shanahan

Gut Feb 1999, 44 (2) 156-162; DOI: 10.1136/gut.44.2.156
Intestinal crypt cell apoptosis in murine acute graft versus host disease is mediated by tumour necrosis factor α and not by the FasL-Fas interaction: effect of pentoxifylline on the development of mucosal atrophy
E Stüber, A Büschenfeld, A von Freier, T Arendt, U R Fölsch

Gut Aug 1999, 45 (2) 229-235; DOI: 10.1136/gut.45.2.229
High Fas ligand expression on lymphocytes in lesions of ulcerative colitis
H Ueyama, T Kiyohara, N Sawada, K Isozaki, S Kitamura, S Kondo, J Miyagawa, S Kanayama, Y Shinomura, H Ishikawa, T Ohtani, R Nezu, S Nagata, Y Matsuzawa

Gut Jul 1998, 43 (1) 48-55; DOI: 10.1136/gut.43.1.48

Main menu